CIK 0001582554
- Non-accelerated filer
- Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463011414
- Phone
- +1 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-14 | MANNINO RAPHAEL J Chief Scientific Officer | Grant or award · Stock Option (right to Buy) | +275,000 | 275,000 | ||
| 2021-09-03 | MANNINO RAPHAEL J Chief Scientific Officer | Other acquisition | +462,150 | 1,919,715 | ||
| 2021-06-19 | MANNINO RAPHAEL J Chief Scientific Officer | Other acquisition | +8,000 | 1,437,565 | ||
| 2021-06-19 | MANNINO RAPHAEL J Chief Scientific Officer | Conversion | +20,000 | 1,457,565 | ||
| 2021-06-19 | MANNINO RAPHAEL J Chief Scientific Officer | Conversion · Series B Preferred Stock | −10 | 0 | ||
| 2021-01-01 | MANNINO RAPHAEL J Chief Scientific Officer | Grant or award · Stock option (right to buy) | +200,000 | 200,000 | ||
| 2020-06-23 | MANNINO RAPHAEL J Chief Scientific Officer | Other acquisition | +3,000 | 1,429,565 | ||
| 2020-06-17 | MANNINO RAPHAEL J Chief Scientific Officer | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2020-01-01 | MANNINO RAPHAEL J Chief Scientific Officer | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2019-06-21 | MANNINO RAPHAEL J Chief Scientific Officer | Other acquisition | +2,000 | 1,426,565 | ||
| 2019-02-11 | MANNINO RAPHAEL J Chief Scientific Officer | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2018-06-21 | MANNINO RAPHAEL J Chief Scientific Officer | Purchase · Series B Convertible Preferred Stock | +10 | $1,000.00 | $10K | 10 |
| 2018-04-30 | MANNINO RAPHAEL J Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2017-09-11 | MANNINO RAPHAEL J Chief Scientific Officer | Purchase | +5,000 | $1.41 | $7K | 1,424,565 |
Page 1 of 1 · 14 trades